Based on these observations, coupled with the relationship between LCN2/CTSD on tumor invasion progression, we speculated that the anti-invasive effect of LCN2 on GBM cell may be partly through CTSD expression and possibly involved in another molecular mechanism. The gene discussed is LCN2; the disease is glioblastoma.